|
|
 |
|
Viewing report
|
|
|
|
Biobanks - 2011 Yearbook
GBI Research, March 2011, Pages: 76
“Biobanks - 2011 Yearbook”. It provides key data, information and analysis of the 40 major biobanks in the world. The report provides information on the population-based biobanks, disease based biobanks, brain biobanks, stem cell biobanking, twin registries, children biobanks and many national biobanks. This report provides comprehensive analysis of funding, harmonization, cost of biobanking, and partnership structure. It also reviews the factors determining the success and failure of the biobanks. It is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by a team of industry experts.
Biobanking is a relatively new field with promising potential. It presents a host of opportunities and challenges. The number of biobanks increased significantly during the period 1989-1999. Funding patterns have changed as biobanks have evolved. In a comparative study of more than 100 biobanks around the world, many biobanks were found to be stand-alone, with the whole funding received by the government of the country. Around 70% biobanks are stand-alone, whereas only 30% are partnered with other biobanks or institutions. With globalization and the growing interest in trans-national sharing of biobank resources, there is an increasing push to harmonize biobank processes and regulations. The setting up of the biobank is the most costly phase of a biobank’s development and lifespan. The maintenance of a biobank is marginal compared to the set up of a biobank.
Scope
The scope of this report includes -
- Comprehensive study of 40 major biobanks in the world along with the current trends in biobanking.
- Detailed account of population-based biobanks, disease-based biobanks, brain biobanks, stem cell biobanking, twin registries, children biobanks and many national biobanks.
- Comparative study of major issues of biobanks including funding, harmonization, cost of biobanking, partnership structure, regulatory and ethical issues.
- In-depth analysis of the major development in the leading segments of the biobanks with key emphasis on major challenges in the biobanking sector.
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Evaluate major biobanks in the world, their service providers, research collaborations and private sector involvement.
- Analyze issues of funding, harmonization, cost of biobanking, and partnership structure that determine strength and limitation of a biobank.
- Develop strategic initiatives by understanding the key focus of research of the leading biobanks.
- Accelerate and strengthen your market position by identifying key biobanks for mergers, acquisitions and strategic partnerships to accelerate research and development.
- Device better strategies through the understanding of key drivers and barriers in the market.
- Develop understanding on recent developments in biobanking regulatory frameworks and ethical issues like informed consent, withdrawal of ownership, confidentiality and commercialization.
|
|
|
|
